$27.66+$0.52 (+1.90%)as of market close, Jul 24, 2026
CSGP — CoStar Group Inc. stock price, chart and key statistics
Key stats
Price data
- Price
- $27.66
- Change YTD
- -57.90%
- Next earnings
- Jul 28, 2026 · After close
- Market cap
- 11.3B
- Enterprise value
- 11.1B
- Shares outstanding
- 408.4M
- 52W low
- $26.68
- 52W high
- $97.43
- From 52W high
- -71.62%
- From 52W low
- +3.65%
- 52W range
- 1%
- Beta
- 0.73
Volume
- Rel volume
- 1.54×
- 30D volume
- 7.1M
- 30D $ vol
- 209.2M
Fundamentals
- Sales (ttm)
- 3.4B
- Sales/share
- $8.35
- EPS (ttm)
- $0.06
- FCF (ttm)
- 231M
- FCF/share
- $0.57
- Book value/share
- $19.38
- Net margin
- 0.73%
- ROE
- 0.31%
- ROA
- 0.24%
- Debt / equity
- 0.13×
- Current ratio
- 2.20
Growth (CAGR, ttm) · 10Y
- Sales
- +16.32%
- Net income
- +2.50%
- FCF
- +5.85%
- Shares
- +2.29%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +0.01%
- Sales/share
- +13.71%
- FCF/share
- +3.48%
- Book value/share
- +14.96%
- Price
- +2.21%
- Total return
- +2.21%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 455.4×
- Fwd P/E
- 15.1×
- P/S (ttm)
- 3.3×
- P/B (mrq)
- 1.4×
- P/FCF (ttm)
- 48.9×
- EV/EBITDA (fy)
- 58.0×
- EV/Sales (ttm)
- 3.2×
- FCF yield (ttm)
- 2.05%
- Buyback yield (ttm)
- 8.73%
- Shareholder yield (ttm)
- 8.73%
Vs own 10Y history
- P/E
- 92nd
- P/S
- 0th
- P/B
- 0th
- P/FCF
- 18th
Bar = where today's multiple sits in CSGP's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
+1.90%
1W
-7.14%
1M
-7.23%
3M
-26.02%
YTD
-57.90%
1Y
-69.61%
5Y
-68.34%
Financial statements
Open full CSGP financials →Related Financials
1MCoStar Group Inc. (CSGP) trades at $27.66 with a live price and an interactive chart covering 28+ years of daily price history, plus key valuation metrics. ChartRow also publishes CSGP's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full CSGP financial statements →
